Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults

Cancer Causes and Control

Volumn 9, Issue 4, 1998, Pages 403-410

  Calle, Eugenia E ^a   Murphy, Terrell K ^a   Rodriguez, Carmen ^a   Thun, Michael J ^a   Heath Jr , Clark W ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

Cohort studies; Diabetes mellitus; Pancreatic cancer; Risk factors; United States

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 0031670178     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008819701485     Document Type: Article

References (41)

1. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307-14.
2. Balkau B, Barrett-Connor E, Eschwege E, Richard JE, Claude JR, Ducimetiere P. Diabetes and pancreatic carcinoma. Diabetes Metab 1993; 19: 458-62.
3. Chow WH, Gridley G, Nyrén O, et al. Risk of pancreatic cancer following diabetes mellitus: a nationalwide cohort study in Sweden. J Natl Cancer Inst 1995; 87: 930-1.
4. Cuzick J, Babiker AG. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer 1989; 43: 415-21.
5. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. JAMA 1995; 273: 1605-9.
6. Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 1990; 45: 816-20.
7. Friedman GD, Van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 1993; 22: 30-7.
8. Gullo L, Pezzilli R, Morselli-Labate AM, and the Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N Engl J Med 1994; 331: 81-4.
9. Hiatt RA, Klatsky AL, Armstrong MA. Pancreatic cancer, blood glucose and beverage consumption. Int J Cancer 1988; 41: 794-7.
10. Jain M, Howe GR, St. Louis P, Miller AB. Coffee and alcohol as determinants of risk of pancreas cancer: a case-control study from Toronto. Int J Cancer 1991; 47: 384-9.
11. Kalapothaki V, Tzonou A, Hsieh C-c, Toupadaki N, Karakatsani A, Trichopoulos D. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control 1993; 4: 375-82.
12. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970; 44: 673-86.
13. La Vecchia C, Negri E, D'Avanzo B, et al. Medical history, diet and pancreatic cancer. Oncology 1990; 47: 463-6.
14. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70: 950-3.
15. Mills PK, Beeson WL, Abbey DE, Fraser GE, Phillips RL. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer 1988; 61: 2578-85.
16. Morris DV, Nabarro JDN. Pancreatic cancer and diabetes mellitus. Diabetic Med 1984; 1: 119-21.
17. Norell S, Ahlbom A. Diabetes, gall stone disease, and pancreatic cancer [Letter]. Br J Cancer 1986; 54: 377-8.
18. Ragozzino M, Melton LJ III, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chron Dis 1982; 35: 13-9.
19. Whittemore AS, Paffenbarger RS Jr, Anderson K, Halpern J. Early precursors of pancreatic cancer in college men. J Chron Dis 1983; 36: 251-6.
20. Wynder EL, Mabuchi K, Maruchi N, Fortner JG. Epidemiology of cancer of the pancreas. J Natl Cancer Inst 1973; 50: 645-67.
21. Davey-Smith G, Egger M, Shipley MJ, Marmot MG. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 1992; 136: 1110-4.
22. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arngvist HJ, Larsson J. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993; 159: 101-7.
23. Noy A, Bilezikian JP. Clinical review 63, diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab 1994; 79: 1223-31.
24. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arngvist HJ, Larsson J. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 1993; 80: 1047-50.
25. Warshaw AL, Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-65.
26. Garfinkel L. Selection, follow-up, and analysis in the American Cancer Society prospective studies. Mongr Natl Cancer Inst 1985; 67: 49-52.
27. Stellman SD, Garfinkel L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst 1986; 76: 1057-63.
28. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993; 137: 235-41
29. World Health Organization. International Classification of Diseases. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Vol. 1. Ninth Revision. Geneva, Switzerland: World Health Organization, 1977.
30. Rothman KJ. Modern Epidemiology. Boston, MA (USA): Little, Brown, 1986.
31. Flanders WD. Approximate variance formulas for standardized rate ratios. J Chronic Dis 1984; 37: 449-53.
32. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (B) 1972; 34: 187-220.
33. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantatitive Methods. New York, NY (USA): Van Nostrad Reinhold Company, 1982.
34. Fisher WE, McCullough PJ, Ray MB, Rogers DH, Bell RH Jr. Diabetes enhances growth of pancreatic carcinoma cells. Surgery 1988; 104: 431-6.
35. Fisher WE, McCullough PJ, Ramo OJ, Bell RH Jr. Further studies of enhanced growth of pancreatic carcinoma in diabetes. J Surg Res 1996; 63: 310-3.
36. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic terms. J Surg Res 1996; 63: 310-3.
37. Harlow SD, Linet MS. Argument between questionnaire data and medical records: evidence for accuracy of recall. Am J Epidemiol 1989; 129: 233-48.
38. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 1989; 79: 1554-6.
39. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes 1987; 36: 523-34.
40. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992; 15: 815-9.
41. Martin BC, Warram JH, Krowlewski AS, Bergman RN, Soeldner JS, Kahn CR. Rule of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925-9.